Cross Country Healthcare Newsroom

Cross Country Healthcare Analyst Ratings

BenzingaOct 21 11:02 ET

Truist Financial Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Announces Target Price $15

Moomoo NewsOct 21 08:31 ET

Barrington Maintains Cross Country Healthcare(CCRN.US) With Buy Rating, Maintains Target Price $19

Moomoo NewsSep 20 10:31 ET

Buy Rating Affirmed for Cross Country Healthcare Amidst Growth and Strategic Optimism

TipRanksSep 20 10:19 ET

Cross Country Healthcare Analyst Ratings

BenzingaAug 8 12:54 ET

Buy Rating Affirmed for Cross Country Healthcare Amidst Resilient Q2 Performance and Strategic Growth Potential

TipRanksAug 8 10:10 ET

Truist Securities Maintains Hold on Cross Country Healthcare, Raises Price Target to $17

BenzingaAug 1 09:21 ET

Cross Country Healthcare Analyst Ratings

BenzingaAug 1 09:20 ET

Oppenheimer Maintains Cross Country Healthcare(CCRN.US) With Hold Rating

Moomoo NewsAug 1 08:31 ET

Benchmark Co. Maintains Cross Country Healthcare(CCRN.US) With Buy Rating, Maintains Target Price $19

Moomoo NewsAug 1 08:31 ET

Cross Country Healthcare (CCRN) Receives a Rating Update From a Top Analyst

TipRanksAug 1 07:37 ET

JMP Securities Maintains Cross Country Healthcare(CCRN.US) With Hold Rating

Moomoo NewsAug 1 00:32 ET

Cross Country Healthcare Analyst Ratings

BenzingaMay 6 10:34 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cross Country Healthcare (CCRN), Castle Biosciences (CSTL) and Andlauer Healthcare Group (OtherANDHF)

TipRanksMay 6 09:25 ET

Cross Country Healthcare Analyst Ratings

BenzingaMay 2 11:27 ET

Analysts Offer Insights on Healthcare Companies: Cross Country Healthcare (CCRN) and Bio-Techne (TECH)

TipRanksMay 2 07:25 ET

JMP Securities Sticks to Its Hold Rating for Cross Country Healthcare (CCRN)

TipRanksMay 2 01:00 ET

Analysts Offer Insights on Healthcare Companies: Cross Country Healthcare (CCRN) and Viking Therapeutics (VKTX)

TipRanksFeb 27 11:00 ET

Cross Country Healthcare Analyst Ratings

BenzingaFeb 27 10:56 ET

UBS Adjusts Cross Country Healthcare Price Target to $19 From $22, Maintains Neutral Rating

MT NewswiresFeb 23 11:58 ET